about
Vaccine development for tuberculosis: current progressHost immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosisTuberculosis: From an incurable scourge to a curable disease - journey over a millenniumPrime-boost approaches to tuberculosis vaccine developmentTackling tuberculosis: Insights from an international TB Summit in LondonInterpreting measures of tuberculosis transmission: a case study on the Portuguese population.Multidrug resistant tuberculosis: A challenge in clinical orthopedics.Vaccines against poverty.History of BCG Vaccine.Oral vaccination with lipid-formulated BCG induces a long-lived, multifunctional CD4(+) T cell memory immune responseUpdate on cutaneous tuberculosisRecent Advances in Defining the Immunoproteome of Mycobacterium tuberculosisSecretory phosphatases deficient mutant of Mycobacterium tuberculosis imparts protection at the primary site of infection in guinea pigs.The role of B cells and humoral immunity in Mycobacterium tuberculosis infectionImmunology studies in non-human primate models of tuberculosisVaccines and global health.DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosisGene expression profiling identifies candidate biomarkers for active and latent tuberculosisHIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in MiceProtection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4(+) T cells but no increase in avidity for Ag85ADuration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.Diterpenes as lead molecules against neglected tropical diseases.Kinetics of IFN-gamma and TNF-alpha gene expression and their relationship with disease progression after infection with Mycobacterium tuberculosis in guinea pigs.Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines.Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaRecombinant vaccines and the development of new vaccine strategies.Mycobacterial L-forms are found in cord blood: A potential vertical transmission of BCG from vaccinated mothers.Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape.Integrative immunoinformatics for Mycobacterial diseases in R platform.Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.Immunology and world health: key contributions from the global community.Rhodococcus equi (Prescottella equi) vaccines; the future of vaccine development.Emerging drugs and alternative possibilities in the treatment of tuberculosis.Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South AfricaPrime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis.Vaccine research and development: tuberculosis as a global health threat.Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults
P2860
Q26827737-8946C366-5F33-463A-92E5-29914B862B84Q26863391-BE3DA0B9-4A17-4312-BB31-CE3644E6E436Q26865560-D31A6CBE-3ED0-41D8-AC2D-14CC58DEE07BQ27024526-CADE4712-6994-45CF-A883-C900BE11BFACQ28602294-2771A7DF-E533-4C1F-B1C9-CD601C22CA09Q31166349-9E801FEF-FD63-40F7-980D-058B78F968E5Q33735674-AED3D1B9-183F-426E-926F-9514F5798635Q34119892-C553E90B-D9E5-4C36-9D36-11B698B1D704Q34370165-FBFA019F-791E-4AD8-A55E-EE2059A4C2C8Q34438532-70D5506D-B4F3-4F96-A09D-2098C8EA3B68Q34504457-125037FC-89A5-45DD-812D-ACEEA9EA53F1Q35018134-F86C4701-28B1-45F4-9DE3-3E5AEB46429FQ35035800-80144412-364B-42DA-A058-587EEE028B92Q35039807-0047391C-D588-4126-88B5-243A7E101887Q35116998-F94455C6-BFC4-442D-B41F-6CE6995B45DEQ35137116-86827A6B-96B1-4F1E-B12F-F9F696C7A56CQ35758746-572CAC9B-BC8A-4A36-A1DD-744481824F5CQ35896225-701F0C75-5D83-4FD4-9BCF-4869BA2054F3Q35906290-E5983B22-A01D-439E-BD2F-9D07D1A534E7Q36079913-B36727D5-7CE6-4E31-A2DF-E7EC4F8DB2DFQ36096965-FB22E343-C9FB-4A33-B3F6-ACFC64D86C1DQ36154690-07A11D6C-B804-4E44-97E5-E5D8D4452168Q36206465-E8CCD3CB-FFD0-4FCE-8E1F-BDA11396ACC3Q36793138-162BA402-AC99-4325-986E-96513B0C0242Q36849770-4A82F841-AF78-4BDD-8503-0A5AA7AFF123Q36981626-07DD4027-7C70-4C19-B939-37090A6C68ACQ37370940-96F86ABB-8D47-45FB-818B-F6E709894B10Q37375946-83DA5CCF-AF29-497C-8527-EF94F972B773Q37455406-02771962-6DF2-4023-88E8-36FF5145E856Q37601159-AD06D8B5-A109-478C-BD8D-87E52F25336DQ38031924-4E0E5A7F-0ED8-4CA5-A96F-2C00EC401E14Q38059150-0A2A1AC8-F5FF-4172-A8D2-12ABFBB9D7D4Q38079607-9AD2432B-BE7D-4E1D-9D22-AB37BF67A0BBQ38221560-2EF5CE62-8D80-469C-9FC6-E8019F185C6AQ38724073-C6D8D7AD-C90E-4DEC-BFD7-998273769C02Q39125505-45A32814-D061-4E33-9D6C-7C82E1DFD5EDQ39202380-8CEE1F4C-054A-45E6-AF0E-A842CDAB4733Q40006239-009BF792-6074-4BD5-84D6-2D6A348143E1Q40059597-387F5EBD-4C8F-4225-8A3B-09073DBC3C9BQ41015596-8DB67C2E-0F89-40A6-B77D-FB198DFA42A5
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@ast
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@en
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@nl
type
label
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@ast
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@en
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@nl
prefLabel
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@ast
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@en
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@nl
P2860
P3181
P356
P1476
Tuberculosis vaccines: beyond bacille Calmette-Guerin
@en
P2860
P304
P3181
P356
10.1098/RSTB.2011.0097
P407
P5008
P577
2011-10-12T00:00:00Z